Financial Ratios

VIVO BIO TECH LTD.

NSE : NABSE : 511509ISIN CODE : INE380K01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE42.87-1.52 (-3.42 %)
PREV CLOSE ( ) 44.39
OPEN PRICE ( ) 45.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 80469
TODAY'S LOW / HIGH ( )42.00 47.40
52 WK LOW / HIGH ( ) 18.1156
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.771.544.243.451.82
   CEPS(Rs)7.986.768.407.465.92
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)34.4932.2930.6025.5921.77
   Tax Rate(%)42.8150.7534.07-4.42-23.17
Margin Ratios
   Core EBITDA Margin(%)42.2731.3134.4022.5317.04
   EBIT Margin(%)24.3917.0123.7513.298.00
   Pre Tax Margin(%)8.928.7116.657.693.27
   PAT Margin (%)5.104.2910.988.034.03
   Cash Profit Margin (%)23.0518.7721.7817.3713.09
Performance Ratios
   ROA(%)2.182.238.297.733.93
   ROE(%)5.415.0615.3514.8510.21
   ROCE(%)11.269.5519.4714.159.58
   Asset Turnover(x)0.430.520.750.960.97
   Sales/Fixed Asset(x)0.380.470.710.951.09
   Working Capital/Sales(x)6.5212.858.127.448.87
Efficiency Ratios
   Fixed Capital/Sales(x)2.652.141.421.060.92
   Receivable days86.2868.6062.6562.2965.98
   Inventory Days62.8781.9984.0962.0351.72
   Payable days87.8459.11134.26165.95183.87
Valuation Parameters
   PER(x)10.9225.6711.315.6330.41
   PCE(x)2.425.865.702.609.36
   Price/Book(x)0.561.231.570.762.54
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.702.341.780.831.60
   EV/Core EBITDA(x)4.027.435.143.689.40
   EV/EBIT(x)6.9813.767.476.2720.05
   EV/CE(x)0.731.001.190.771.63
   M Cap / Sales0.561.101.240.451.23
Growth Ratio
   Net Sales Growth(%)0.45-0.74-6.46-0.8618.79
   Core EBITDA Growth(%)35.05-9.5242.8131.50-13.52
   EBIT Growth(%)44.00-28.8967.2164.61-29.93
   PAT Growth(%)19.55-61.2427.9297.51-27.96
   EPS Growth(%)14.42-63.5322.8589.27-42.54
Financial Stability Ratios
   Total Debt/Equity(x)1.171.420.700.670.81
   Current Ratio(x)1.321.171.291.361.34
   Quick Ratio(x)1.000.750.680.850.90
   Interest Cover(x)1.582.053.352.371.69
   Total Debt/Mcap(x)2.091.150.450.880.32

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.